In the fast-paced world of drug development, time is often the most precious commodity. For biotech companies working on oral ...
It is estimated that 70% to 80% 1 of small molecule drug candidates in development today can be classified as poorly water-soluble. Since poorly soluble drugs are difficult to formulate as tablets, ...
Bringing complex oral drugs to the clinic requires overcoming significant solubility, permeability, and bioavailability challenges. Many early-phase programs stall due to limited API supply, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback